| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |